Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma.

Abstract:

:The expression of pro-gastrin-releasing peptide (proGRP) in medullary thyroid carcinoma (MTC) and other histological types of thyroid carcinoma was studied by an immunohistochemical technique, using polyclonal anti-proGRP antiserum. Immunoreactivity for proGRP was detected exclusively in MTC (n = 7); other histological types (n = 12) were all negative for proGRP. In addition, serum proGRP levels were elevated in patients with primary or recurrent MTC (n = 3), and they changed in parallel with serum calcitonin (CT), and carcinoembryonic antigen (CEA). These results show that proGRP, which is considered to be a specific marker for small-cell lung carcinoma, may be also a potential tumor marker for MTC, in addition to CT and CEA.

journal_name

Oncology

journal_title

Oncology

authors

Inaji H,Komoike Y,Motomura K,Higashiyama M,Ohtsuru M,Funai H,Kasugai T,Koyama H

doi

10.1159/000012148

subject

Has Abstract

pub_date

2000-08-01 00:00:00

pages

122-5

issue

2

eissn

0030-2414

issn

1423-0232

pii

12148

journal_volume

59

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications.

    abstract::Oral cancer is the eleventh most common cancer globally, with well-established major risk factors of tobacco, areca nut, alcohol, and high-risk human papillomavirus (HR-HPV) types 16 and 18. HR-HPV16/18 are the etiologic agents of cervical cancers and a proportion of oropharyngeal cancers. HPV-associated oropharyngeal...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000485322

    authors: Yete S,D'Souza W,Saranath D

    更新日期:2018-01-01 00:00:00

  • 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.

    abstract::Fifteen patients, median age 64 years, presenting with advanced gastrointestinal adenocarcinomas, were included in this study. The treatment combination consisted of folinic acid (200 mg/m2, IV bolus injection) followed by 5-fluorouracil (5-FU; 400 mg/m2, 30-min infusion) for 5 consecutive days and mitomycin C (10 mg/...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226620

    authors: Becouarn Y,Brunet R,Bussières E,Marée D

    更新日期:1988-01-01 00:00:00

  • Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.

    abstract:BACKGROUND:Gemcitabine monotherapy is the cornerstone of the treatment of patients suffering from advanced pancreatic cancer (PC). For a few years, new chemotherapeutic agents and combinations have been under validation. The use of such treatment makes it necessary to determine factors that could predict survival time....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000120627

    authors: Maréchal R,Demols A,Gay F,De Maertelaere V,Arvanitaki M,Hendlisz A,Van Laethem JL

    更新日期:2007-01-01 00:00:00

  • Mitomycin therapy in gastric cancer.

    abstract::Adenocarcinoma of the stomach remains a significant cause of mortality worldwide. The majority of patients present with stage III or IV disease, negating surgery as a curative option. Numerous drugs have been tested over the past 2 decades in single-agent and combination chemotherapy trials. Given by intravenous bolus...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1159/000227249

    authors: Schnall S,Macdonald JS

    更新日期:1993-04-01 00:00:00

  • Models, mechanisms and management of anticipatory nausea and emesis.

    abstract::Anticipatory nausea and vomiting (ANV) are learned responses to chemotherapy that develop in up to 25% of patients by the fourth treatment cycle. Post-treatment nausea and emesis must occur before development of ANV can take place. Certain patient characteristics and other responses to chemotherapy can also be used to...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227633

    authors: Morrow GR,Rosenthal SN

    更新日期:1996-06-01 00:00:00

  • Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years on.

    abstract::Recombinant human granulocyte colony-stimulating factor (G-CSF) has been used worldwide in cancer patients for over 1 year, and (only 5 years from the first publication on the clinical use of this growth factor) experience is rapidly accumulating in many oncological situations. Several randomized studies have confirme...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227333

    authors: Bronchud MH

    更新日期:1994-03-01 00:00:00

  • Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy.

    abstract:BACKGROUND:Anthracycline is used to treat various types of cancer; however, cardiotoxicity negatively affects patient prognosis. OBJECTIVES:The aim of the present study was to investigate serial changes in levels of cardiac troponin I (TnI) and B-type natriuretic peptide (BNP) in patients treated with anthracycline-co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507585

    authors: Oikawa M,Yoshihisa A,Yokokawa T,Misaka T,Yaegashi D,Miyata M,Nakazato K,Ishida T,Takeishi Y

    更新日期:2020-01-01 00:00:00

  • DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.

    abstract:BACKGROUND:We assessed the prognostic value of the nuclear DNA content measured in the primary tumours of 123 patients with stage II or stage III colorectal cancer (CRC). METHODS:Isolated nuclei from paraffin sections were stained with the Feulgen reaction, and DNA was measured using a computer-assisted image analysis...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000098556

    authors: Buhmeida A,Algars A,Ristamäki R,Collan Y,Syrjänen K,Pyrhönen S

    更新日期:2006-01-01 00:00:00

  • Restricted activity of serum blocking factors related to a common tumour antigen in mice.

    abstract::Mice of four different inbred strains (CBA, Balb/c, C57Bl/6 and DBA/2), bearing different transplanted tumours (methylcholanthrene-induced sarcomas, B16 melanoma and P-815 mastocytoma), were tested for cellular immune reactivity to the synthetic encephalitogenic peptide of human myelin basic protein by the leucocyte a...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225732

    authors: Yong WK,Halliday WJ

    更新日期:1983-01-01 00:00:00

  • Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.

    abstract:PURPOSE:Patient nonadherence to oral antineoplastic therapy is a well-recognized barrier to effective treatment. In order to identify patients who may need additional support to become adherent, it is important to have a useful tool that takes into account all the parameters of adherence to prescription. The aim of thi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000342087

    authors: Thivat E,Van Praagh I,Belliere A,Mouret-Reynier MA,Kwiatkowski F,Durando X,Mahammedi H,Dillies AF,Chollet P,Chevrier R

    更新日期:2013-01-01 00:00:00

  • Histological staining by tritiated actinomycin D: a useful tool to study neoplastic cell heterogeneity and estrogen sensitivity of mammary tumors.

    abstract::The MXT mouse transplantable mammary cancer is characterized by significant amounts of steroid hormone receptors. Moreover this model, as other solid tumors, contains diverse subpopulations of neoplastic cells. In the present study we have examined this pattern as well as the influence of exogenous physiologic doses o...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226015

    authors: Kiss R,Leclercq G,Danguy A

    更新日期:1985-01-01 00:00:00

  • Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer.

    abstract:OBJECTIVE:We evaluated the efficacy and safety of bolus 5-fluorouracil (5-FU) and leucovorin combined with weekly paclitaxel (FLTAX) in advanced gastric cancer (GC) patients. METHODS:Patients with untreated stage IV GC received paclitaxel 80 mg/m(2) as a 1-hour infusion, followed by 5-FU 600 mg/m(2) as a bolus infusio...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000334462

    authors: Matsubara J,Shimada Y,Kato K,Nagai Y,Iwasa S,Nakajima TE,Hamaguchi T,Yamada Y,Takagi S,Kobayashi K,Yoshioka A,Nakayama N,Tsuji A

    更新日期:2011-01-01 00:00:00

  • Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.

    abstract:BACKGROUND:Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision surgery is a standard treatment for locally advanced rectal cancer (LARC). Tumor-infiltrating lymphocytes (TILs) have been reported to be associated with tumor response; however, this remains to be established. We previously reported ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508922

    authors: Miyakita H,Sadahiro S,Suzuki T,Chan LF,Ogimi T,Okada K,Yamamoto S,Kajiwara H

    更新日期:2020-01-01 00:00:00

  • Evaluation of chemotherapy in a murine model for bladder cancer.

    abstract::A transplantable transitional cell murine bladder tumor induced by N-[4-(5-nitro-2-furyl)-thiazolyl] formamide (FANFT) was characterized by tumor growth, survival time and response to chemotherapy drugs, cis-dichloro-trans-dihydroxy-bis-iso-propylamine platinum IV (CHIP), cis- diaminedichloro platinum II (DDP), cyclop...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225822

    authors: Murphy GP,Pontes JE,Williams PD

    更新日期:1984-01-01 00:00:00

  • Plasma diamine oxidase activity is a useful biomarker for evaluating gastrointestinal tract toxicities during chemotherapy with oral fluorouracil anti-cancer drugs in patients with gastric cancer.

    abstract:OBJECTIVES:Diamine oxidase (DAO) is an enzyme that catalyzes oxidation and is highly active in the mature upper villus cells of the intestinal mucosa. This study sought to evaluate plasma DAO activities during adjuvant chemotherapy in patients with gastric cancer. METHODS:We investigated 20 patients with gastric cance...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000336799

    authors: Namikawa T,Fukudome I,Kitagawa H,Okabayashi T,Kobayashi M,Hanazaki K

    更新日期:2012-01-01 00:00:00

  • Ondansetron: a cost-effective advance in anti-emetic therapy.

    abstract::A cost-effectiveness analysis is one form of full economic evaluation where drug acquisition costs and the costs that are incurred as a result of using a particular treatment are assessed together with clinical efficacy. This paper reviews two such studies. One of the studies was a prospective randomised cost-effectiv...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227175

    authors: Cox F,Hirsch J

    更新日期:1993-05-01 00:00:00

  • Perspectives in adjuvant therapy of gastric cancer.

    abstract::Although the incidence of gastric cancer has been declining in Western countries, it is still a major health problem and a leading cause of cancer mortality. Surgery is the mainstay of treatment for gastric adenocarcinoma. However, even among patients undergoing gastrectomy with curative intent, 5-year survival rates ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000258494

    authors: De Vita F,Vecchione L,Galizia G,Di Martino N,Fabozzi T,Catalano G,Ciardiello F,Orditura M

    更新日期:2009-01-01 00:00:00

  • Animal models in drug development: historical aspects.

    abstract::The historical aspects of drug development and evaluation are anecdotically related. Clinical trials have proven the effectiveness of animal tests in the vast majority of cases, and the effort has been well spent. Similar of more noteworthy success may be obtainable with model systems in the study of prostatic cancer....

    journal_title:Oncology

    pub_type: 历史文章,杂志文章

    doi:10.1159/000225197

    authors: Gaunt R

    更新日期:1977-01-01 00:00:00

  • Single, high-dose intravenous dexamethasone as an antiemetic in cancer chemotherapy.

    abstract::The antiemetic effect of graded, single high-dose intravenous dexamethasone was studied in 27 patients receiving combination chemotherapy with either doxorubicin (50 mg/m2) or cis-platinum (100 mg/m2). A total of 57 cycles were individually evaluated, utilizing a detailed rating system. Nausea and vomiting did not occ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000226099

    authors: Zaglama NE,Rosenblum SL,Sartiano GP,Brady M,Gonzalez MF,Valdivieso JG

    更新日期:1986-01-01 00:00:00

  • Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.

    abstract::Thirty-eight patients with metastatic renal-cell carcinoma (RCC) and 1 patient with a second primary RCC were treated with coumarin and cimetidine. Patients received 400 mg cimetidine p.o. daily and after 1 week 100 mg coumarin p.o. daily in addition until tumour progression. Two complete remission (30 and 50+ months)...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000226905

    authors: Kokron O,Maca S,Gasser G,Schmidt PR

    更新日期:1991-01-01 00:00:00

  • Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.

    abstract:OBJECTIVE:To report the outcomes of surgical resection of borderline resectable (BL) and locally advanced (LA) 'unresectable' pancreatic cancer after neoadjuvant chemotherapy. METHODS:A review of a prospectively maintained database for pancreatic resections was undertaken to identify patients undergoing resection for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000371745

    authors: Addeo P,Rosso E,Fuchshuber P,Oussoultzoglou E,De Blasi V,Simone G,Belletier C,Dufour P,Bachellier P

    更新日期:2015-01-01 00:00:00

  • Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

    abstract::The prognosis of brain glioblastoma is still very poor and the median survival time is generally less than 6 months. At present, no chemotherapy has appeared to influence its prognosis. On the other hand, recent advances in brain tumor biology have suggested that brain tumor growth is at least in part under a neuroend...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227533

    authors: Lissoni P,Meregalli S,Nosetto L,Barni S,Tancini G,Fossati V,Maestroni G

    更新日期:1996-01-01 00:00:00

  • Chemoradiotherapy alone as the standard treatment of epidermoid esophageal carcinoma.

    abstract:OBJECTIVES:Surgery has traditionally been the treatment of choice for patients with potentially resectable esophageal carcinoma. Recently, however, definitive chemoradiotherapy (CRT) has been suggested as a preferred treatment modality. In this study, CRT results with or without surgery are compared. METHODS:A total o...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000333448

    authors: Salek R,Tabrizi FV,Bezenjani SE,Saedi HS,Ashkiki MH,Hosainzadeh SM,Mohtashami S

    更新日期:2011-01-01 00:00:00

  • Cells from normal and malignant human colon mucosa differentially inhibit embryonic cell aggregation.

    abstract::A model system for studying some aspects of the interaction of cancer cells in tumors and their surrounding nonmalignant tissue is the co-culture of cancer cells and embryonic chick neural retinal cells in gyratory shakers. Neural retina cell aggregation, under these conditions, has been shown to be differentially inh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225573

    authors: Maslow DE,Mayhew E,Mittleman A

    更新日期:1981-01-01 00:00:00

  • Fetal antigens in the precursor stages of gastric cancer.

    abstract::Gastric epithelial cells, identified in biopsy specimens from individuals with varying degrees of gastritis and cellular atypia, were classified according to morphology and reactivity with an adult tissue-absorbed rabbit antibody to 2nd trimester human fetal tissue. Sections of stomach from normal individuals and pati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225796

    authors: Higgins PJ,Correa P,Cuello C,Lipkin M

    更新日期:1984-01-01 00:00:00

  • Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.

    abstract::Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurable disease on entry into the study. No responses were observed while 3 patients,...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226836

    authors: Benedetti Panici P,Scambia G,Greggi S,Salerno G,Cento R,Mancuso S

    更新日期:1990-01-01 00:00:00

  • Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.

    abstract::An immunohistochemical stain to the c-ErbB-2 protein was performed in 225 paraffin-embedded tissue blocks from patients with locally advanced gastric cancer who underwent curative resection. The overexpression of the c-ErbB-2 protein was observed in 27.4% of the patients. The c-ErbB-2 positivity showed a statistically...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227559

    authors: Lee HR,Kim JH,Uhm HD,Ahn JB,Rha SY,Cho JY,Lee JI,Lee KH,Chung HC,Roh JK,Min JS,Lee KS,Shin DH,Kim BS,Hong SW,Choi JH

    更新日期:1996-05-01 00:00:00

  • Pharmacokinetic study of S-1 in patients in whom inulin clearance was measured.

    abstract:OBJECTIVE:This pharmacokinetic study of S-1 was conducted in patients in whom glomerular filtration rate (GFR) was directly measured to explore the possibility of adjusting the S-1 dose on the basis of GFR in patients with normal or nearly normal renal function. METHODS:S-1 was given to 12 patients twice daily for 28 ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000337232

    authors: Ando Y,Kawada K,Inada M,Morita S,Mitsuma A,Yasuda Y,Hiramatsu M,Fujimoto Y,Fujita K

    更新日期:2012-01-01 00:00:00

  • Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomas.

    abstract::A pilot study was performed administering PCNU with radiation therapy to treat patients with high-grade astrocytomas and to explore the toxic effects of this drug regimen. PCNU at an initial dose of 110 mg/m2 i.v. was administered to 14 patients within 4 weeks after completion of cranial irradiation. Courses were repe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226854

    authors: Feun LG,Maor M,Stewart DJ,Leavens ME,Savaraj N,Bodey GP

    更新日期:1990-01-01 00:00:00

  • Phase II study of UFT plus leucovorin in colorectal cancer.

    abstract::The activity and toxicity of UFT (Tegafur and Uracil) in a 4:1 molar concentration, plus leucovorin (LV), were evaluated in the treatment of 45 patients with advanced, bidimensionally measurable metastatic colorectal carcinoma. Initially 350 and later 300 mg/m2/day, plus 150 mg LV, as administered in divided doses eve...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227741

    authors: Pazdur R

    更新日期:1997-01-01 00:00:00